Skip to main content

Animations

MJFF Publications

6151 - 6160 of 6422 Results
Title
Year
  • Year
  • 2025
  • 2007
  • 2021
  • 2023
  • 2019
  • 2019
  • 2024
  • 2017
  • 2018
  • 2021
  • Summary Details
    OPEN
    Title: A study of RNA splicing and protein expression in the living human brain
    Journal Name: PLOS One
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0332651
    Citation Count: 0
  • Summary Details
    OPEN
    Title: TNF-α knockout and minocycline treatment attenuates blood–brain barrier leakage in MPTP-treated mice
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2006.11.012
    Citation Count: 166
  • Summary Details
    OPEN
    Title: Music to move persons with Parkinson’s disease: a personalized approach
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00415-021-10615-5
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Genome-wide case-only analysis of gene-gene interactions with known Parkinson’s disease risk variants reveals link between LRRK2 and SYT10
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00550-9
    Citation Count: 5
  • Summary Details
    OPEN
    Title: mTOR hyperactivity mediates lysosomal dysfunction in Gaucher's disease iPSC-neuronal cells
    Journal Name: Disease Models & Mechanisms
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1242/dmm.038596
    Citation Count: 60
  • Summary Details
    OPEN
    Title: The Michael J. Fox Foundation for Parkinson’s Research Strategy to Advance Therapeutic Development of PINK1 and Parkin
    Journal Name: Biomolecules
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/biom9080296
    Citation Count: 22
  • Summary Details
    OPEN
    Title: P2RX7, an adaptive immune response gene, is associated with Parkinson's disease risk and age at onset
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/1877718x241296015
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Increased brain expression of GPNMB is associated with genome wide significant risk for Parkinson’s disease on chromosome 7p15.3
    Journal Name: neurogenetics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s10048-017-0514-8
    Citation Count: 70
  • Summary Details
    OPEN
    Title: Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4)
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-181434
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Profiling Parkinson’s disease cognitive phenotypes via resting-state magnetoencephalography
    Journal Name: Journal of Neurophysiology
    Publisher: American Physiological Society
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1152/jn.00316.2021
    Citation Count: 8
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.